The 36 rating InvestorsObserver gives to Arena Pharmaceuticals, Inc. (ARNA) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 42 percent of stocks in the Biotechnology industry, ARNA’s 36 overall rating means the stock scores better than 36 percent of all stocks.
ARNA has an Overall Score of 36. Find out what this means to you and get the rest of the rankings on ARNA!